ReCardioids: a robust human heart organoid platform to model doxorubicin- and radiotherapy-induced cardiotoxicity
Emil Rehnberg, Bjorn Baselet, Emre Etlioglu, Zoe Janssen, Ben Cools, Cynthia Van Rompay, Randy Vermeesen, Lorenzo Moroni, Sarah Baatout, Kevin Tabury
The paper develops reCardioids, a human heart organoid model, to study doxorubicin and radiotherapy-induced cardiotoxicity, showing improved cellular maturity and response to treatment.
bioRxiv · Jun 2, 2026 · PreprintBioengineering